Compare CVS Health Corp (CVS) vs Nasdaq Inc (NDAQ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CVS Health Corp vs Nasdaq Inc — how do they compare? CVS Health Corp trades at $86.25 (market cap $112.29B), while Nasdaq Inc trades at $92.6 (market cap $51.63B). The key difference: CVS Health Corp is far larger — about 2.2× Nasdaq Inc's market cap, and CVS Health Corp pays the higher dividend (3.03%). Which is the better fit depends on your goals — on Pluang, investors hold CVS Health Corp for 83 Days and Nasdaq Inc for 125 Days on average.
| CVS | NDAQ | |
|---|---|---|
Market Cap | $112.29B | $51.63B |
Volume | 7,763,676 | 2,668,175 |
Sector | Health | Financials |
52-Week High | $110.60 | $100.98 |
52-Week Low | $70.08 | $76.85 |
Typical Hold Time | 83 Days | 125 Days |
Enterprise Value | $174.64B | $58.09B |
Dividend Yield | 3.03% | 1.26% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $87.95, up 1.76% with strong analyst support (85% buy ratings) and a $111.20 consensus price target suggesting 26% upside. Recent quarterly earnings consistently beat expectations, with Q2 2026 EPS of $2.58 surpassing the $1.85 estimate. Revenue growth remains solid at $402.07 billion for 2025, though net margins compressed to 1.18%. Technical indicators show a bullish overall signal with support at $87 and resistance at $89.
The outlook remains positive given CVS's dominant market position and Medicare expansion plans, but investors face risks from reimbursement pressures and ongoing legal investigations. Earnings growth and successful execution of healthcare services integration represent the primary catalysts for continued stock appreciation.
Nasdaq (NDAQ) trades at $91.93, down 0.37% on the day, with a bearish technical signal despite recent earnings beats. The company reported strong fundamentals with 2025 revenue of $8.26 billion and net income of $1.79 billion, yielding a net margin of 21.64%. Recent news highlights growth in its Financial Technology segment, including AI enhancements to the Calypso platform and new client adoptions like HSBC.
The outlook is positive given analyst consensus with a $110.71 price target and 61% buy ratings, though near-term technical weakness and high valuation ratios pose risks. Key catalysts include continued tech adoption and cross-selling, while risks involve market volatility and execution challenges in a competitive landscape.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About CVS Health Corp
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →About Nasdaq Inc
Founded in 1971, Nasdaq is primarily known for its equity exchange, but in addition to its market-services business (about 35% of sales), the company sells and distributes market data as well as offers Nasdaq-branded indexes to asset managers and investors through its information-services segment (30%). Nasdaq's corporate-services business (20%) offers listing services and related investor relations products to publicly traded companies and through the company's market technology group (15%), Nasdaq facilitates the exchange operations of other exchanges throughout the world and provides financial compliance services.
Read more on NDAQ →
